There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

The SWI/SNF Ig-Fold for Transcription Factor Interactions or 'SWIFT' domain on mSWI/SNF chromatin remodeling complexes engage ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene ...

A newly identified enzyme appears to control tau production, brain inflammation, and aging. Researchers at the University of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...

Operational Resilience & Collaboration: Across every trend, the need for resilient, adaptable, and collaborative approaches ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...